Due to Hurricane Milton, we will be closing at 12pm on Wednesday and the entire day on Thursday to ensure the safety of our team and patients.

Expect slight delays starting on Friday due to the team catching up. We thank you for your patience and understanding.

Introducing Sublingual Semaglutide Tablets! An INJECTION-FREE option for GLP-1 compounded preparations. Ask your pharmacist about sublingual semaglutide tablets today!

Functional Medicine

  1. April 12, 2024

    Patient Case: The Use of Methylene Blue in Canine Methemoglobinemia

    There's an interesting case study in the Journal of Veterinary Internal Medicine about a dog (juvenile, mixed breed) who presented with cyanosis, tachycardia, tachypnea, lethargy, exercise intolerance, and aggression when touched on the head.

    There's a lot going on there. To cut to the chase, a methylene blue IV administration (1 mg/kg) took care of the problem, which turned out to be a pair of gene mutations that led to reductase deficiency and then methemoglobinemia.

    The symptoms returned after 11 days, but a slightly higher dose of the methylene blue fixed the issue and now Fido (not his real name) gets that higher concentration every other day which keeps his methemoglobin concentration at bay.

    Methemoglobinemia can affect different animals differently, and while the solution seems straightforward — methylene blue — it's obviously critical to choose the right concentration and possibly

    Read More
  2. March 30, 2023

    Mayo Clinic review finds LDN can help with fibromyalgia

    A new study out of the Mayo Clinic (with a partner in South Korea) found that low-dose naltrexone seems both to work just great for combating the symptoms of fibromyalgia. It was already used off-label for that purpose, but the authors wanted to add a dose of science — to “systematically assess the current evidence.”

    Voila! In looking at the studies out there, they found that LDN helped manage the symptoms of fibromyalgia with “no severe adverse events were reported.”

    Read More